PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 23, 2019. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The...
PRESS RELEASE Lund Sweden, May 3, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease has been...
PRESS RELEASE Lund 2 May, 2019 - Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are...
PRESS RELEASE Active Biotech's Annual Report 2018 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed. The English version will be...
First quarter in brief Active Biotech's partner NeoTX entered clinical collaboration with AstraZeneca to evaluate ANYARA ("naptumumab") in combination with IMFINZI®...
PRESS RELEASE The Board of Directors of Active Biotech AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Thursday, May 23, 2019, at 5 pm at the company's...
PRESS RELEASE Lund Sweden, April 5 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) Active Biotech completes sale of property Active Biotech AB (publ) has today completed the sale of the...
PRESS RELEASE Lund Sweden, April 4 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) Extraordinary General Meeting of Active Biotech An Extraordinary General Meeting of Active Biotech AB (publ) was...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.